Abstract
A little over 3 years have elapsed since Yanagisawa and his colleagues48 named and described the chemistry and sustained constrictor activity of the polypeptide (endothelin-1) that accumulates in the supernatant of cultured endothelial cells. During these years, interest in this polypeptide has escalated to such a degree that several hundred papers have now been published on the topic. Other endothelins (endothelin-2, endothelin-3, and mouse β-endothelin) have been identified,49,50 chemically homologous polypeptides have been isolated from the venom of the asp Atractaspis engaddensis,24 and their mode of action has been identified.49,50 In addition, attention has been directed to their possible involvement in a variety of pathological conditions, including asthma, vasospasm, hypertension, renal failure, and myocardial infarction.33,34
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cernacek, P., and D. J. Stewart. Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem. Biophys. Res. Commun. 161: 562–567, 1989.
Chester, A. H., M. R. Dashwood, J. G. Clarke, S. W. Larking, G. J. Davies, S. Tadjkarimi, A. Maseri, and M. H. Yacoub. Influence of endothelin on human coronary arteries and localization of its binding sites. Am. J. Cardiol. 63: 1395–1398, 1989.
Clozel, J. P., and M. Clozel. Effects of endothelin on the coronary vascular bed in open-chest dogs. Circ. Res. 65: 1193–1200, 1989.
Cocks, T. M., N. L. Faulkner, K. Sudhir, and J. Angus. Reactivity of endothelin-1 on human and canine large veins compared with large arteries in vitro. Eur. J. Pharmacol. 171: 17–24, 1989.
Davenport, A. P., A. J. Kaumann, J. A. Hall, D. J. Nunez, and M. J. Brown. [lz5I]endothelin binding in mammalian tissue: relation to human atrial inotropic effects and coronary contraction. Br. J. Pharmacol. 96: 102, 1989.
Davenport, A. P., D. J. Nunez, J. A. Hall, A. J. Kaumann, and M. J. Brown. Autoradio-graphic localization of binding sites for porcine [1251lendothelin-1 in humans, pigs, and rats: functional relevance in humans. J. Cardiovasc. Pharmacol. 13(Suppl. 5 ): 166170, 1989.
Ezra, D., R. E. Goldstein, J. F. Czaja, and G. Z. Feuerstein. Lethal ischemia due to intra-coronary endothelin in pigs. Am. J. Physiol. 257 (Heart Circ. Physiol. 26 ): H339 - H343, 1989.
Fukuda, Y., Y. Hirata, H. Yoshimi, T. Kojima, Y. Kobayashi, M. Yanagisawa, and T. Masaki. Endothelin in a potent secretagogue for atrial natriuretic peptide in cultured rat atrial myocytes. Biochem. Biophys. Res. Commun. 155: 167–172, 1988.
Fukuda, K., S. Hori, M. Kusuhara, T. Satoh, S. Kyotani, S. Handa, Y. Nakamura, H. Oona, and K. Yamaguchi. Effect of endothelin as a coronary vasoconstrictor in the Langendorff-perfused rat heart. Eur. J. Pharmacol. 165: 301–304, 1989.
Galron, R., Y. Kloog, A. Bdolah, and M. Sokolovsky. Functional endothelin/sarafotoxin receptors in rat heart myocytes: structure-activity relationships and receptor subtypes. Biochem. Biophys. Res. Commun. 163: 936–943, 1989.
Gu X. H., D. J. Casley, and W. G. Nayler. Characterization of [125I]endothelin-1 binding sites in rat cardiac membrane fragments. J. Cardiooasc. Pharmacol. 13 (Suppl. 5): 5171–173, 1989.
Gu, X. H., D. J. Casley, and W. G. Nayler. Sarafotoxin S6b displaces specifically bound 1251-endothelin. Eur. J. Pharmacol. 162: 509–510, 1989.
Gu, X. H., D. J. Casley, M. Cincotta, and W. G. Nayler. [1251]endothelin-1 binding to brain and cardiac membranes from normotensive and spontaneously hypertensive rats. Eur. J. Pharmacol. 177: 205–209, 1990.
Hirata, Y., Y. Fukuda, H. Yoshima, T. Emori, M. Shichira, and F. Maruma. Specific receptors for endothelin in cultured rat cardiocytes. Biochem. Biophys. Res. Commun. 160: 1438–1444, 1989.
Hirata, Y., H. Yoshima, T. Emori, M. Shichira, F. Marumo, T. X. Watanabe, S. Kumugaye, K. Nakajima, T. Kimura, and S. Sakakibara. Receptor binding activity and cytosolic free calcium response by synthetic endothelin analogues in cultured rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 160: 228–234, 1989.
Hoyer, D., C. Waeber, and J. M. Palacois. [1251]endothelin-1 binding sites: autoradio-graphic studies in the brain and periphery of various species, including humans. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S162 - S165, 1989.
Hu, J. R., U. G. Berninger, and R. E. Lang. Endothelin stimulates atrial natriuetic peptide (ANP) release from rat atria. Eur. J. Pharmacol. 164: 177–178, 1988.
Hu, J. R., R. Von Harsdorf, and R. E. Lang. Endothelin has potent inotropic effects in rat atria. Eur. J. Pharmacol. 158: 275–278, 1988.
Ishikawa, T., M. Yanagisawa, S. Kimura, K. Goto, and T. Masaki. Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria. Am. J. Physiol. 255 (Heart Circ. Physiol. 24 ): H970 - H973, 1988.
Ishikawa, T., M. Yanagisawa, S. Kimura, K. Goto, and T. Masaki. Positive chronotropic effects of endothelin, a novel endothelium-derived vasoconstrictor peptide. Pflugers Arch. 413: 108–110, 1989.
Karawatowska-Prolopczuk, E., and A. Wennmalm. Effects of endothelin on coronary flow, mechanical performance, oxygen uptake, and formation of purines and on outflow of prostacyclin in the isolated rabbit heart. Circ. Res. 66: 46–54, 1990.
Kasuya, Y., T. Ishirawa, M. Yanagisawa, S. Kimura, K. Goto, and T. Masaki. Mechanism of contraction to endothelin in isolated porcine coronary artery. Am. J. Physiol. 257 (Heart Circ. Physiol. 26): H1828 - H1835, 1989.
Kasuya, Y., Y. Takuwaa, M. Yanagisawa, S. Kimura, K. Goto, and T. Masaki. Endothelin1 induces vasoconstriction through two functionally distinct pathways in porcine coronary artery: contribution of the phosphoinositide turnover. Biochem. Biophys. Res. Commun. 161: 1049–1055, 1989.
Kloog, Y., I. Ambar, M. Sololovsky, E. Kochua, Z. Wollberg, and A. Bdholah. Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. Science 242: 268–270, 1988.
Kurihara, H., K. Yamaoki, R. Nagai, M. Yoshizumi, F. Takaku, H. Satoh, and J. Inui. Endothelin: a potent vasoconstrictor associated with coronary vasospasm. Life Sci. 44: 1937–1943, 1989.
Lang, R. E., H. Tholken, D. Ganten, F. C. Luft, H. Ruskoako, and T. Unger. Atrial natriuretic factor-a circulating hormone stimulated by volume loading. Nature 314: 264–266, 1985.
Ledsome, J. R., N. Wilson, A. Courneya, and A. J. Rankin. Release of atrial natriuretic peptide by atrial distension. Can. J. Physiol. Pharmacol. 63: 739–742, 1986.
Liu, J. J., D. J. Casley, and W. G. Nayler. Ischaemia causes externalization of endothelin1 binding sites in rat cardiac membranes. Biophys. Biochem. Res. Commun. 164: 1220–1225, 1989.
Liu, J. J., R. Chen, D. J. Casley, and W. G. Nayler. Effect of ischemia and reperfusion on [’25I]endothelin-1 binding in rat cardiac membranes. Am. J. Physiol. (in press).
Liu, J. J., X. H. Gu, D. J. Casley, and W. G. Nayler. Reoxygenation but neither hypoxia nor intermittent ischaemia increases [1251]endothelin-1 binding to rat cardiac membranes. J. Cardiovasc. Pharmacol. 15: 436–443, 1990.
Miyauchi, T., M. Yanagisawa, T. Tomizawa, Y. Sugishita, N. Suzuki, M. Fujino, R. Ajisaka, K. Goto, and T. Masakl. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 1: 53, 1989.
Moravec, C. S., E. E. Reynolds, R. W. Stewart, and M. Bond. Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem. Biophys. Res. Commun. 159: 14–18, 1989.
Nayler, W. G. Endothelin: a mini review. J. Appl. Cardiol. 4: 495–504, 1989.
Nayler, W. G. Endothelin: isoforms, binding sites and possible implications in pathology. Trends Pharmacol. Sci. 11: 96–99, 1990.
Nayler, W. G., X. H. Gu, D. J. Casley, S. Panagiotopoulos, J. Liu, and P. L. Mottram. Cyclosporine increases endothelin-1 binding site density in cardiac cell membranes. Biochem. Biophys. Res. Commun. 163: 1270–1274, 1989.
Nayler, W. G., and J. J. Liu. Nifedipine and experimental cardioprotection. Cardiovasc. Drugs Ther. (in press).
Nayler, W. G., J. Liu, S. Panagiotopoulos, and D. J. Casley. Streptozotocin-induced diabetes reduces the density of endothelin-binding sites in rat cardiac membranes. Br. J. Pharmacol. 97: 993–995, 1989.
Power, R. F., J. Wharton, S. P. Salas, S. Kanse, M. Ghatei, S. R. Bloom, and J. M. Polak. Autoradiographic localisation of endothelin binding sites in human and porcine coronary arteries. Eur. J. Pharmacol. 160: 199–200, 1989.
Schramm, M., G. Thomas, M. Towart, and G. Franckowiak. Novel dihydropyridines with positive inotropic action through activation of Ca“ channels. Nature 303: 535–537, 1983.
Shah, A. M., M. J. Lewis, and A. H. Henderson. Inotropic effects of endothelin in ferret ventricular myocardium. Eur. J. Pharmacol. 163: 365–367, 1989.
Simonson, M. J., S. Wann, P. Mene, G. R. Dubyaw, M. Kester, Y. Nakazato, and J. R. Sedo. Endothelin stimulates phosphorylase C, Na-/H` exchange, c-fos expression, and mitogenesis in rat mesangial cells. J. Clin. Invest. 83: 708–712, 1989.
Simpson, A. W. M., and C. C. Ashley. Endothelin-evoked Ca“ transients and oscillations in AIO vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 163: 1223–1229, 1989.
Vigne, P., M. Lazdunski, and C. Frelin. The inotropic effect of endothelin-1 on atria involves hydrolysis of phosphatidylinositol. Biochem. Biophys. Res. Commun. 249: 143–146, 1989.
Watanabe, T., K. Kusomoto, T. Kitayoshi, and N. Shimamoto. Positive inotropic and vasoconstrictive effects of endothelin-1 in in vivo and in in vitro experiments: characteristics and the role of L-type calcium channels. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): 108–111, 1989.
Watanabe, T., H. Miyazaki, M. Kondoh, Y. Masuda, S. Kimura, M. Yanagisawa, T. Masaki, and K. Murakami. Two distinct types of endothelin receptors are present on chick cardiac membranes. Biochem. Biophys. Res. Commun. 161: 1252–1259, 1989.
Watanabe, T., N. Suzuki, N. Shimatmoto, M. Jujino, and A. Imada. Endothelin in myocardial infarction. Nature 344: 114 1990.
Yamasaki, H., M. Niwa, K. Yamashita, Y. Kataoka, K. Shigematsu, K. Hashiba, and M. Ozaki. Specific 1251-endothelin-1 binding sites in the atrioventricular node of the porcine heart. Eur. J. Pharmacol. 168: 247–250, 1989.
Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. A novel potent constrictor peptide produced by vascular endothelial cells. Nature 332: 411–415, 1988.
Yanagisawa, M., and T. Masaki. Endothelin, a novel endothelium-derived peptide. Biochem. Pharmacol. 38: 1877–1883, 1989.
Yanagisawa, M., and T. Masaki. Molecular biology and biochemistry of the endothelins. Trends Pharmacol. Sci. 10: 374–378, 1989.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 American Physiological Society
About this chapter
Cite this chapter
Nayler, W.G., Gu, X.H. (1992). Endothelin and the Heart. In: Rubanyi, G.M. (eds) Endothelin. Clinical Physiology Series. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7514-9_10
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7514-9_10
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-7514-9
eBook Packages: Springer Book Archive